Evofem Biosciences, Inc.
EVFM$1M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaSAN DIEGO32 employees
Drugs in Pipeline
4
Phase 3 Programs
4
Upcoming Catalysts
1
Next Catalyst
Jun 18, 2026
13wMarket Overview
Stock performance and key metrics
EVFM News
Catalyst Timeline
1 upcoming, 1 past
Drug Pipeline
AMPHORA
Contraception
Conceptrol
Contraception
EVO100
Sexually Transmitted Diseases
LIPO-202
Central Abdominal Bulging
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
AMPHORA | Phase 3 | Contraception | - | - |
Conceptrol | Phase 3 | Contraception | - | - |
EVO100 | Phase 3 | Sexually Transmitted Diseases | - | - |
LIPO-202 | Phase 3 | Central Abdominal Bulging | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply